| Literature DB >> 24734110 |
Francisco José Mininel1, Carlos Sérgio Leonardo Junior1, Lívia Greghi Espanha2, Flávia Aparecida Resende2, Eliana Aparecida Varanda2, Clarice Queico Fujimura Leite2, Wagner Vilegas3, Lourdes Campaner Dos Santos1.
Abstract
Terminalia is a genus of Combretaceous plants widely distributed in tropical and subtropical regions. Thus, the aim of this study was to quantify the majority compounds of the hydroalcoholic extract (7 : 3, v/v) of the leaves from T. catappa by HPLC-PDA, chemically characterize by hyphenated techniques (HPLC-ESI-IT-MS(n)) and NMR, and evaluate its mutagenic activity by the Salmonella/microsome assay on S. typhimurium strains TA98, TA97a, TA100, and TA102. The quantification of analytes was performed using an external calibration standard. Punicalagin is the most abundant polyphenol found in the leaves. The presence of this compound as a mixture of anomers was confirmed using HPLC-PDA and (1)H and (13)C NMR. Mutagenic activity was observed in strains TA100 and TA97a. As the extract is a complex mixture of punicalagin, its derivatives, and several other compounds, the observed mutagenicity may be explained in part by possible synergistic interaction between the compounds present in the extract. These studies show that mutagenic activity of T. catappa in the Ames test can only be observed when measured at high concentrations. However, considering the mutagenic effects observed for T. catappa, this plant should be used cautiously for medicinal purposes.Entities:
Year: 2014 PMID: 24734110 PMCID: PMC3966358 DOI: 10.1155/2014/676902
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1First-order mass spectrum of the hydroalcoholic extract from the leaves of T. catappa in the negative mode. Range of ions with m/z 100–2000 Da.
Figure 2Punicalagin (1), punicalin (2), gallagic acid (3), and ellagic acid (4). Adapted from Seeram et al. [32].
Identification of substances in T. catappa by FIA-ESI-IT-MSn.
| [M–H]− | MSn ions | Identification |
|---|---|---|
| 1083 | 781 [M-152-152-H]−
| Punicalagin |
| 781 | 601 [M-180-H]− | Punicalin |
| 601 | 409 [M-191-H]− | Gallagic acid |
| 301 | 257 [M-44-H]−
| Ellagic acid |
Figure 3Chromatogram of hydroalcoholic extract of the leaves of T. catappa dissolved in MeOH : H2O (1 : 1 v/v), at 10 mg/mL. The method utilized a hydro column at a flow rate of 1 mL/min with a gradient of 5–60% MeOH for 60 min HPLC-PDA (Jasco), 270 nm. The UV spectra from t 14.75 (peak 1) min and at t 18.86 min (peak 2), characteristic of the α- and β-anomers of punicalagin (1, 2) and ellagic acid (3).
Figure 4Chromatogram of infusion of the leaves of T. catappa. Gradient 5–60% MeOH, 60 min, 270 nm. Peaks 1 and 2 = punicalagins, 3 = ellagic Acid. The UV spectra of peak 1, eluting at t 14.70 min and peak 2 at t 18.70 min, characteristic of the α- and β-punicalagin anomers. Peak 3, at t 47.30 min.
Figure 5Chromatogram peak 1a (α-punicalagin) and peak 1b (β-punicalagin) collected from H2O : MeOH (8 : 2 v/v) at 10 mg/mL of the leaves of T. catappa, eluting at t 15.29 min (1a) and t 21.07 min (1b). The flow rate was 1 mL/min with a gradient 5–30% MeOH for 30 minutes using a hydro column. HPLC-PDA (Jasco), 270 nm. The UV spectra of peak 1, eluting at t 15.29 min (1a) and at t 21.07 (1b) min, characteristic of the α- and β-punicalagin anomers.
Chemical shifts (1H and 13C) of the α- and β-punicalagins in CD3OD isolated from T. catappa.
| Position |
|
| ||||
|---|---|---|---|---|---|---|
|
| Multiplicity (Hz) |
|
| Multiplicity (Hz) |
| |
| 1 | 5.08 | d(3.5) | 89.87 | 4.66 | d(8.0) | 93.77 |
| 2 | 4.87 | dd(3.0, 8.0) | 73.53 | 4.62 | dd(3.0, 8.1) | 75.48 |
| 3 | 5.20 | t(9.3) | 76.08 | 4.92 | t(10.0) | 78.78 |
| 4 | 4.78 | t(9.0) | 70.23 | 4.85 | t(10.0) | 74.88 |
| 5 | 3.23 | t(9.0) | 66.33 | 2.57 | dd(9.9, 11.0) | 71.58 |
| 6a | 2.10 | d(9.9) | 63.63 | 4.05 | d(9.9) | 63.03 |
| 6b | 4.09 | dd(7.0, 7.0) | 63.63 | 4.10 | d(7.8) | 63.03 |
| 9 | 6.52 | s | 105.46 | 6.54 | s | 106.21 |
| 18 | 6.66 | s | 107.41 | 6.68 | s | 106.21 |
| 23 | 6.73 | s | 108.76 | 6.77 | s | 109.51 |
| 46 | 6.94 | s | 110.11 | 6.97 | s | 110.71 |
Parameters for quantification of the isolated compounds.
| Linear coefficient ( | Slope ( | Correlation coefficient | LOD | LOQ | |
|---|---|---|---|---|---|
| Ellagic acid | 21753 | 71514 | 0.998 | 1.00 | 3.04 |
|
| 37326 | 11861 | 0.997 | 10.38 | 31.46 |
|
| 44760 | 16830 | 0.999 | 8.77 | 26.59 |
| Total punicalagins |
|
|
|
|
|
Determining the accuracy of the method for the determination of each of the substances quantified.
| Substances investigated | Repetition (%) | Recovery mean | DP | RSD (%) | ||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| Ellagic acid | 90.4 | 87.75 | 84.52 | 87.56 | 2.94 | 0.03 |
| Total punicalagins | 86.9 | 86.26 | 85.86 | 86.34 | 0.52 | 0.01 |
RSD (%) = RSD: relative standard deviation (100 × SD/mean).
Repeatability test results for each substance quantified.
| Substances investigated | Intraday ( | Interday ( | ||||
|---|---|---|---|---|---|---|
| Mean (%) | DP | RSD (%) | Mean (%) | DP | RSD (%) | |
| Ellagic acid | 87.44 | 0.12 | 0.001 | 87.53 | 0.19 | 0.002 |
| Total Punicalagins | 86.34 | 0.19 | 0.002 | 86.19 | 0.17 | 0.002 |
RSD (%) = RSD: relative standard deviation (100 × SD/mean).
Mutagenic activity expressed as the mean and standard deviation of the number of revertants/plate and mutagenic index (in parenthesis) in Salmonella typhimurium TA98, TA100, TA97a, and TA102 strains treated with hydroalcoholic extract of T. catappa at various doses, with (+S9) or without (−S9) metabolic activation.
| Treatments | Number of revertants (M ± SD)/ plate and MI | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| TA98 | TA100 | TA102 | TA97a | |||||||
| mg/plate | −S9 | +S9 | mg/plate | −S9 | +S9 | −S9 | +S9 | −S9 | +S9 | |
| Terminalia catappa | 0.0a | 16 ± 3 | 68 ± 1 | 0.0a | 93 ± 6 | 87 ± 4 | 352 ± 30 | 435 ± 43 | 172 ± 2 | 99 ± 1 |
| 2.78 | 17 ± 6 (1.1) | 75 ± 7 (1.1) | 1.56 | 91 ± 2 (1.0) | 88 ± 9 (1.0) | 461 ± 11* (1.3) | 481 ± 23 (1.1) | 223 ± 3* (1.3) | 127 ± 3 (1.3) | |
| 5.56 | 21 ± 3 (1.3) | 75 ± 7 (1.1) | 3.12 | 188 ± 19** (2.0) | 90 ± 6 (1.0) | 514 ± 16* (1.5) | 668 ± 75* (1.5) | 252 ± 12* (1.5) | 102 ± 7 (1.0) | |
| 11.12 | 18 ± 5 (1.1) | 57 ± 1 (0.8) | 6.25 | 210 ± 24** (2.3) | 91 ± 6 (1.0) | 653 ± 22* (1.9) | 689 ± 57* (1.6) | 287 ± 14* (1.7) | 95 ± 12 (1.0) | |
| 16.68 | 14 ± 3 (0.9) | 75 ± 4 (1.1) | 9.38 | 40 ± 4 (0.4) | 95 ± 1 (1.1) | 563 ± 32* (1.6) | 728 ± 28* (1.7) | 337 ± 19** (2.0) | 93 ± 10 (0.9) | |
| 22.24 | 2 ± 1 (0.1) | 68 ± 10 (1.0) | 12.5 | Nd | 88 ± 4 (1.0) | 648 ± 32* (1.8) | 621 ± 23* (1.4) | 397 ± 19** (2.3) | 83 ± 2 (0.8) | |
| Ctrol+ | 720 ± 63 | 500 ± 57 | Ctrol+ | 1225 ± 75 | 700 ± 80 | 1143 ± 53 | 1309 ± 38 | 1426 ± 67 | 700 ± 45 | |
*P < 0.05 (ANOVA); **P < 0.01 (ANOVA), 0a: Negative control: dimethyl sulfoxide (DMSO—75 μL/plate); Positive Control: 4-nitro-o-phenylenediamine (10.0 μg/plate—TA98 and TA97a); sodium azide (1.25 μg/plate—TA100); mitomycin (0.5 μg/plate—TA102), in the absence of S9, and 2-anthramine (1.25 μg/ plate—TA98, TA100, TA97a); 2-aminofluorene (10.0 μg/plate—TA102), in the presence of S9. Nd: not determined.